Sarah Johnson

Manager, Prospect Management And Research at Pulmonary Fibrosis Foundation

Sarah Johnson is an experienced professional in prospect management and research, currently serving as the Manager at the Pulmonary Fibrosis Foundation since August 2019. At this organization, Sarah has focused on comprehensive prospect research, data analysis, and strategy development. Notable accomplishments include the creation of an automated wealth screening process and an in-house system to assess donor inclination. Prior to this role, Sarah was a Senior Analyst at the University of Chicago for over a decade, where responsibilities encompassed biodata management, capacity research, and independent subject research. Sarah also held various positions at the University of Chicago, including Research Analyst, Project Manager, and Receptionist, as well as internship roles in theatre organizations. Sarah holds a BA in Performance Studies from Willamette University and an MA in Theatre Studies from the University of Arizona.

Location

Chicago, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices


Pulmonary Fibrosis Foundation

We imagine a world without pulmonary fibrosis. The Pulmonary Fibrosis Foundation is focused on our mission to act as the trusted resource for all who are affected by this disease. Our signature programs include: PFF Care Center Network PFF Patient Registry PFF Patient Communication Center PFF Ambassador Program An international network of support groups and online communities The PFF Summit Comprehensive disease education materials Our expert Medical Advisory Board and the biennial PFF Summit allow us to maintain an ongoing dialogue with physicians, researchers, industry representatives, and the patient community. This creates a collaborative environment that will help us achieve many of our goals. Our peer-reviewed research program supports projects that improve understanding of pulmonary fibrosis and will lead to successful therapies. We have developed significant relationships with industry partners and upheld our position as the honest broker to inform those affected by pulmonary fibrosis of important scientific breakthroughs.


Employees

11-50

Links